Senior Care Pharmacy Coalition Comments on Part D Proposed Rule
January 16, 2018 Via Electronic Submission The Honorable Seema Verma, M.P.H. Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attn: CMS-4182-P 7500 Security Boulevard Baltimore, MD 21244 Dear Administrator Verma: The Senior Care Pharmacy Coalition (SCPC) appreciates the opportunity to comment on the proposed rule entitled “Medicare Program: Contract Year read more…
SCPC Outlines PBM Reforms Needed to Protect Consumers, Elderly Patients, LTC Pharmacies
Tells House Energy and Commerce Health Panel Medicare Part D Has Become Oligopolistic Market Benefitting Only PBMs and Their Conglomerates…Read More.
New Report on Prescription Drug Costs: PBMs “Rife with Potential Conflicts of Interest”
SCPC Praises Senate HELP Committee’s Ongoing Examination of Drug Costs, says “PBM Oligopoly Maintains Anti-Competitive Stranglehold on LTC Pharmacies and Patients Under Their Care”…Read More.
New SCPC Comments to FTC Detail Steps to Foster Competition in Pharmaceutical Pricing and Supply Chain
2017 Year-End Focus on Drug Pricing by Senate HELP, House Energy and Commerce Committees Demonstrate Ongoing Saliency of Examining PBM Market Manipulation…Read More.
National LTC Pharmacy Group Praises Proposed CMS Rule for Recognizing PBM Abuses, Proposing Ways to Stop Them
SCPC Also Lauds Implementation of 2016 CARA Bill Recognizing Essential Difference Between LTC and Retail Pharmacies…Read More.
National Pharmaceutical Council (NPC) Survey Spotlights PBM Credibility, Trust Deficit
Just One-Third of Employers Rate Their PBM as “Very Trustworthy”…Read More.
Nation’s Independent Long Term Care Pharmacies Commend Administration for Nomination of Alex Azar II for Secretary of the U.S. Department of Health and Human Services (HHS)
SCPC today commended President Trump for his nomination of Alex Azar for Secretary of the Department of Health and Human Services (HHS)…Read More.
Time to Pull the Plug on Unaccountable PBM Middlemen
Draining the “Washington Swamp” is a staple of today’s political and campaign discourse. But there also exists a health policy “swamp” brought to light at the recent Health, Education, Labor and Pensions Committee hearing regarding the prescription drug distribution chain…Read More.
THE PHARMACEUTICAL SUPPLY CHAIN: GROSS DRUG EXPENDITURES REALIZED BY STAKEHOLDERS
Berkley Research Group
Within the U.S. healthcare system, the flow of dollars in the pharmaceutical marketplace is a complex process involving a variety of stakeholders and myriad rebates, discounts, and fees…View the Report.
PBMI Report Shows Changes in Pharmacy Benefit Design to Meet Cost Challenges
Although employers continue to cite managing drug cost trend as the number one goal, they are addressing this challenge head on by implementing significant changes in drug benefit design…View the Report.